Inhibitory effect of procaterol on exercise dynamic lung hyperinflation during the 6-min walk test in stable patients with chronic obstructive pulmonary disease

Arzneimittel-Forschung/Drug Research

Volumn 61, Issue 1, 2011, Pages 8-13

  Satake, Masahiro ^a   Takahashi, Hitomi ^b   Sugawara, Keiyu ^a,b   Kawagoshi, Atsuoshi ^a,b   Tamaki, Akira ^c   Homma, Mitsunobu ^b   Morita, Ryou ^d   Sato, Kazuhiro ^d   Sano, Masaaki ^d   Shioya, Takanobu ^a  

^a AKITA UNIVERSITY   (Japan)

^b Division of Pediatrics Akita Municipal General Hospital   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchodilator; CAS 62929 91 3; Dyspnea; End expiratory lung volume; Exercise dynamic lung hyper inflation; Procaterol hydrochloride; Six minute walk test

Indexed keywords

PLACEBO; PROCATEROL;

6 MINUTE WALK TEST; AGED; ARTICLE; BORG SCALE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CROSSOVER PROCEDURE; DRUG EFFECT; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; LUNG FUNCTION TEST; LUNG INFLATION; MALE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT RESPONSE; VITAL CAPACITY;

EID: 79951860937     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296162     Document Type: Article

References (28)

1. Fletcher CM, Pride NB. Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Chiba symposium. Thorax . 1984;39:81-5. (Pubitemid 14150164)
2. National Heart, Lung and Blood Institute, National Institute of Health, the World Health Organization. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available from: www.goldcopd.com. Accessed: 2010-2-1.
3. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. AmRev Respir Dis . 1993;148:1351-7.
4. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;153:967-75. (Pubitemid 26081647)
5. O'Donnell DE, Chau LKL, Bertley JC, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysilogic mechanism. Am J Respir Crit Care Med. 1997;155:109-15. (Pubitemid 27053150)
6. O'Donnell DE, D'Arsigny C, Fitzpatrick M, Webb KA. Exercise hypercapnea in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. AmJ Respir Crit Care Med. 2002;166:663-8. (Pubitemid 34971847)
7. Diaz O, Villafranca C, Ghezzo H, Borzone G, Levia A, Millic-Emil J, et al. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J. 2000;16:269-75. (Pubitemid 30627482)
8. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. AmJ Respir Crit Care Med. 2001;164:770-7. (Pubitemid 32881912)
9. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. AmJ Respir Crit Care Med. 1998;158:1557-65.
10. American Thoracic Society. 2002ATS Statement: Guidelines for six-minute walk test. Am J Respir Crit Care Med. 2003;166:111.
11. American Thoracic Society/American College of Chest Physicians. 2003ATS/ACCP Statement: on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211-277.
12. Sciurba F, Criner GJ, Lee SM, Mohsenifer Z, Shade D, Silvka W, et al. Six-minute walk distance in chronic obstructive pulmonary disease. Reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med. 2003;167:1522-7. (Pubitemid 37363362)
13. Yabuuchi Y, Yamahsita S, Tei SS. Pharmacological studies of OPC-2009, a newly synthesized selective beta adrenoceptor stimulant, in the bronchomotor and cardiovascular system of the anaesthetized dog. J Pharmacol Exp Ther . 1977;202:326-36. (Pubitemid 8168196)
14. Mirza ZN, Tokuyama K, Arakawa H, Kato M, Mochizuki H, Morikawa A. Inhaled procaterol inhibits histamine-induced airflow obstruction and microvascular leakage in guinea pig airways with allergic inflammation. Clin Exp Allergy. 1998;28:644-52. (Pubitemid 28238280)
15. Sukisaki T, Senjyu H, Oishi K, Rikitomi N, Ariyoshi K. Single dose of inhaled procaterol has a prolonged effect on exercise performance of patients with COPD. Physiother Theory Prac. 2008;24:255-63. (Pubitemid 351896712)
16. Shioya T, Satake M, Sato K, Sano M, Sugawara K, Takahashi H, et al. Long-term effect of the b 2-receptor agonist procaterol on daily life performance and exercise capacity in patients with stable chronic obstructive pulmonary disease. Arzneimittelforschung. 2008;58:24-8.
17. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. AmRev Respir Dis . 1995;152: S77-120.
18. Faggiano P, D'Aloia A, Gualeni A, Glordano A. Assessment of oxygen uptake during the 6-minute walking test in patients with heart failure: Preliminary experience with a portable device. AmHeart J. 1997;13A:203-6.
19. Schulz H, Helle S, Heck H. The validity of the telemetric system CORTEX X1 in the ventilatory and gas exchange measurement during exercise. Int J Sports Med. 1997;18: 454-7. (Pubitemid 27434474)
20. Borg GA. Psychophysical basis of perceived exertion. Med Sci Sports Exerc . 1982;14:377-81.
21. Mahler DA, Donohue JF, Barbee RA, Goldman MD, Gross NJ, Wisniewski ME, et al. Efficacy of salmeterol xinaforate in the treatment of COPD. Chest. 1999;115:957-965. (Pubitemid 29193661)
22. Newton MF, O'Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest. 2002;121:1042-50. (Pubitemid 34280421)
23. Fujimoto K, Yoshiike F, Yasuo M, Kitaguchi Y, Urushibara K, Kubo K, et al. Effects of broncodilators on dynamic hyperinflation following hyperinflation in patients with COPD. Respirology. 2007;12:93-9. (Pubitemid 44968206)
24. O'Donnell DE, Voduc N, Fitzpatrick M, Webb KA. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J. 2004;24:86-94. (Pubitemid 39029073)
25. Honma I, Obata T, Shibuya M, Uchida M. Gate mechanism in breathlessness caused by chest wall vibration in humans. J Appl Physiol. 1984;56(1):8-11. (Pubitemid 14144303)
26. Killan KJ, Bucens DD, Campbell EJM. Effect of breathing patterns on the perceived magnitude on added loads breathing. J Appl Physiol. 1982;52:578-84. (Pubitemid 12041098)
27. O'Donnell DE, McGuire M, Samis L, Webb KA. The impact of exercise recording on breathlessness in patients with severe chronic airflow limitation. Am J Respir Crit Care Med. 1995;152:2005-13.
28. rd ed. 2009.